Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.660
+0.050 (1.92%)
At close: May 12, 2025, 4:00 PM
2.550
-0.110 (-4.14%)
After-hours: May 12, 2025, 7:45 PM EDT
Anixa Biosciences Employees
As of October 31, 2024, Anixa Biosciences had 5 total employees, including 4 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,496,600
Market Cap
85.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ANIX News
- 16 hours ago - Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting - PRNewsWire
- 12 days ago - Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th - PRNewsWire
- 4 weeks ago - Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio - PRNewsWire
- 4 weeks ago - Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology - PRNewsWire
- 5 weeks ago - Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th - PRNewsWire
- 6 weeks ago - Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines - PRNewsWire
- 7 weeks ago - Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine - PRNewsWire
- 2 months ago - Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th - PRNewsWire